News – Endpoints News

Analyzing the Endpoints 100; ‘Most favored nation’ targets revealed; Biotech slump makes leases a liability; and ...

Yesterday

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

2 days ago

Trump asks 'very tough hombre' Dr. Oz to lead MFN talks

2 days ago

US warns drugmakers against misrepresenting cost of imported products

2 days ago

CHMP clears path for GSK’s Blenrep relaunch, recommends four other drugs

2 days ago

Kura spells out pivotal AML trial win as it gears up to compete with Syndax

2 days ago

GLP-1s may cut cancer risk; Gyre’s stock falls after hep B data and offering

2 days ago

Federal judge extends order blocking RFK Jr. from reorganizing HHS

2 days ago

Gilead notches another Phase 3 win for Trodelvy in triple-negative breast cancer

2 days ago

Geoffrey Porges exits Schrödinger with CFO swap; A new board seat for AstraZeneca's Pascal Soriot

2 days ago

Volastra unveils first human data of its solid tumor drug target

2 days ago

Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst

2 days ago

GSK’s Nucala wins COPD approval, stoking rivalry with Dupixent

2 days ago

Roche confirms overall survival benefit for PI3K inhibitor in breast cancer

2 days ago

Jazz outlines full survival data for lung cancer drug Zepzelca

2 days ago

Updated: FDA expects 'timely availability' of Covid shots as advisors update formula recommendation

2 days ago

House passes Trump tax bill with PBM and orphan drug reforms included

2 days ago

FDA chief to senators: 3,000+ staff departures won't delay user fee targets

2 days ago

Updated: Hinge Health jumped 18% on its first day as the digital health IPO market reawakens

3 days ago

Cigna, Novo offer lower GLP-1 prices to lure patients to brand-name drugs

3 days ago

FDA names acting head of inspections; J&J again advocates for tax policies as alternative to tariffs

3 days ago

The ‘MAHA report’: Four key takeaways on vaccines, medicine and the pharma industry

3 days ago

Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

3 days ago

An unpredictable year for healthcare

3 days ago

12 3 4 Next page Last page